[1] Bakusic J, Schaufeli W, Claes S, et al. Stress, burnout and depression: a systematic review on DNA methylation mechanisms[J]. J Psychosom Res, 2017, 92:34-44.
[2] 申秋艳,罗伟生.表观遗传机制与肝纤维化研究进展[J].广西医学,2020,42(6):75 5-758.
[3] 吴元,张文涛,马文超, 等.SOX7启动子甲基化对膀胱癌增殖及凋亡的影响[J]. 医学研究生学报,2019,32(12):1285-1290.
[4] Lakshmi Narasimhan R, Liang G. The role of DNA methylation in cancer[J]. Adv Exp Med Biol, 2016, 945:151-172.
[5] Zeybel M, Hardy T, Robinson S M, et al. Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease[J]. Clin Epigenetics, 2015, 14, 7(1):25.
[6] Wang Y, Chen L, Pandak W M, et al. High glucose induces lipid accumulation via 25-hydroxycholesterol DNA-CpG methylation[J]. iScience, 2020, 23(5): 101102.
[7] Wang H, Sit W H, Tipoe G L, et al. Comparative proteomic analysis of fibrotic liver of rats fed high fat diet contained lard versus corn oil[J]. Clin Nutr, 2017, 36(1): 198-208.
[8] Ferrari L, Vicenzi M, Tarantini L, et al. Effects of physical exercise on endothelial function and DNA methylation[J]. Int J Environ Res Public Health, 2019, 16(14): 2530.
[9] Chatterjee B, Ghosh K, Kanade S R. Curcumin-mediated demethylation of the proximal promoter CpG island enhances the KLF4 recruitment that leads to increased expression of p21Cip1 in vitro[J]. J Cell Biochem, 2019, 120(1): 809-820.
[10] Peng W U, Huang R, Xiong Y L, et al. Protective effects of curcumin against liver fibrosis through modulating DNA methylation[J]. Chin J Nat Med, 2016, 14(4): 255-264.
[11] Yang J J, Yang Y, Zhang C, et al. Epigenetic silencing of LncRNA ANRIL enhances liver fibrosis and HSC activation through activating AMPK pathway[J]. J Cell Mol Med, 2020, 24(4): 2677-2687.
[12] 马宁珠,赖敏芳,殷蕾, 等.肝纤维化的表观遗传学研究进展[J].生命的化学,2020,40(02):205-210.
[13] Kumar P, Raeman R, Chopyk D M, et al. Adiponectin inhibits hepatic stellate cell activation by targeting the PTEN/AKT pathway[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(10): 3537-3545.
[14] Bian E B, Huang C, Wang H, et al. DNA methylation: new therapeutic implications for hepatic fibrosis[J]. Cell Signal, 2013, 25(1): 355-358.
[15] Lin C C, Lin W N, Cho R L, et al. Induction of HO-1 by mevastatin mediated via a Nox/ROS-dependent c-Src/PDGFRα/PI3K/Akt/Nrf2/ARE cascade Suppresses TNF-α-Induced lung inflammation[J]. J Clin Med, 2020, 15;9(1):226.
[16] Yang J, Zhang L, Jiang Z, et al. TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression[J]. Theranostics, 2019, 9(20): 5810.
[17] Tao H, Huang C, Yang J J, et al. MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats[J]. Toxicology, 2011, 290(2-3): 327-333.
[18] 张恬莹,兰涛,魏玲玲, 等.甲基化在肝纤维化过程中的作用及其机制的研究进展[J].中国普外基础与临床杂志,2019,26(02):229-235.
[19] Wu Y, Bu F, Yu H, et al. Methylation of Septin9 mediated by DNMT3a enhances hepatic stellate cells activation and liver fibrogenesis[J]. Toxicol Appl Pharmacol, 2017, 315: 35-49.
[20] Ellik Z M, Idilman I S, Kartal A, et al. Evaluation of magnetic resonance elastography and transient elastography for liver fibrosis and steatosis assessments in the liver transplant setting[J]. Turk J Gastroenterol, 2022, 33(2): 153.
[21] Ehnert S, Aspera-Werz R H, Ruo B M, et al. Hepatic osteodystrophy—molecular mechanisms proposed to favor its development[J]. International Journal of Molecular Sciences, 2019, 20(10): 2555.
[22] Komatsu Y, Waku T, Iwasaki N, et al. Global analysis of DNA methylation in early-stage liver fibrosis[J]. BMC Med Genomics, 2012, 5(1): 1-12.
[23] Song S Z, Lin S, Liu J N, et al. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway[J]. J Cell Physiol, 2019, 234(10):18587-18601.
[24] Wang Y, Chen C, Deng Z, et al. Repression of TSC1/TSC2 mediated by MeCP2 regulates human embryo lung fibroblast cell differentiation and proliferation[J]. Int J Biol Macromol, 2017, 96: 578-588.
[25] Li B, Zhao J, Ma J, et al. Overexpression of DNMT1 leads to hypermethylation of H19 promoter and inhibition of Erk signaling pathway in disuse osteoporosis[J]. Bone, 2018, 111: 82-91.
[26] Yang J J, She Q, Yang Y, et al. DNMT1 controls LncRNA H19/ERK signal pathway in hepatic stellate cell activation and fibrosis[J]. Toxicol Lett, 2018, 295: 325-334.
[27] Lyu S Y, Xiao W, Cui G Z, et al. Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis[J]. Front Genet, 2023, 14: 1124330.
[28] Zhang F, Zhang J, Shan B, et al. Zebularine induces apoptosis of esophageal cancer cells via demethylation SFRP2/Dkk3 to regulate Wnt/β-catenin signaling pathway[J]. Acta Pharmaceutica Sinica, 2021: 1384-1390.
[29] Zhou P, Lu Y, Sun X H. Zebularine suppresses TGF-beta-induced lens epithelial cell-myofibroblast transdifferentiation by inhibiting MeCP2[J]. Mol Vis, 2011, 17: 2717.
[30] 朱红.番泻苷A通过抑制DNMT1介导的PTEN高甲基化改善四氯化碳诱导的小鼠肝纤维化[D]. 安徽医科大学,2021. |
